Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $50.61 | Total: $253.04 |
| 1 | 10 | $42.87 | Total: $428.68 |
| 1 | 25 | $36.32 | Total: $907.96 |
| 1 | 50 | $30.96 | Total: $1,548.00 |
| 1 | 100 | $26.79 | Total: $2,679.23 |
Overview
Elamipretide (MTP-131) is a mitochondria-targeted antioxidant tetrapeptide (D-Arg-dimethylTyr-Lys-Phe-NH2) that reduces toxic reactive oxygen species (ROS) production and stabilizes cardiolipin, with blood-brain-barrier permeability. It is a potential therapeutic agent in the rare disease of Barnes syndrome.
Chemical Properties
| Molecular Formula | C32H49N9O5 |
| Molecular Weight | 639.79 |
| CAS Numbers | 736992-21-5 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | [C@H](CC1=C(C)C=C(O)C=C1C)(C(N[C@H](C(N[C@@H](CC2=CC=CC=C2)C(N)=O)=O)CCCCN)=O)NC([C@@H](CCCNC(=N)N)N)=O |
Storage and Handling
0C Short Term, -20C Long Term
References
Petcherski A, et al. Elamipretide Promotes Mitophagosome Formation and Prevents Its Reduction Induced by Nutrient Excess in INS1 ?-cells. J Mol Biol. 2018 Dec 7;430[24] 4823-4833.
Customers who bought this product also bought:
-
$128.70
-
$13.00
-
$14.30
-
$76.70
